Anne Mackinnon

Astrocytes: biology and pathology

It's Good to Feel Better But It's Better To Feel Good and Even Better to Feel Good as Soon as Possible for as Long as Possible. Response Criteria and the Importance of Change at OMERACT 10: Figure 1.

Rheumatoid arthritis

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Accelerated Systemic Autoimmunity in the Absence of Somatic Hypermutation in 564Igi: A Mouse Model of Systemic Lupus with Knocked-In Heavy and Light Chain Genes

Hydroxychloroquine: From Malaria to Autoimmunity

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

Anti–N‐methyl‐D‐aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus

Cognitive impairment in multiple sclerosis

Female Bias in Systemic Lupus Erythematosus is Associated with the Differential Expression of X-Linked Toll-Like Receptor 8

Neuropsychological Impairment in Systemic Lupus Erythematosus: A Comparison with Multiple Sclerosis

Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma

The potential pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus

Fibromyalgia in Systemic Lupus Erythematosus: Prevalence and Clinical Implications

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II

Determinants of Health-related Quality of Life in Adults with Congenital Heart Disease

Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality

Polymyositis and dermatomyositis

119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands

Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort{

Predictors of cognitive dysfunction in patients with systemic lupus erythematosus

Influence of coping skills on health‐related quality of life in patients with systemic lupus erythematosus

U.S. Medical Eligibility Criteria for Contraceptive Use, 2016

Religion, Spirituality, and Health: The Research and Clinical Implications

Lupus in Baltimore: evidence-based ‘clinical pearls’ from the Hopkins Lupus Cohort

Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management

Fibromyalgia is a major contributor to quality of life in lupus.

Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life.

Neurocognitive abnormalities in offspring of mothers with systemic lupus erythematosus

Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosus.

A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE)